Your browser doesn't support javascript.
loading
Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells.
Tekpli, Xavier; Urbanucci, Alfonso; Hashim, Adnan; Vågbø, Cathrine B; Lyle, Robert; Kringen, Marianne K; Staff, Anne Cathrine; Dybedal, Ingunn; Mills, Ian G; Klungland, Arne; Staerk, Judith.
  • Tekpli X; Nordic European Molecular Laboratory (EMBL) Partnership, Centre for Molecular Medicine Norway, University of Oslo, Blindern, P.O. Box 1137, 0318 Oslo, Norway ; Department of Genetics, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway.
  • Urbanucci A; Nordic European Molecular Laboratory (EMBL) Partnership, Centre for Molecular Medicine Norway, University of Oslo, Blindern, P.O. Box 1137, 0318 Oslo, Norway ; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Hashim A; Nordic European Molecular Laboratory (EMBL) Partnership, Centre for Molecular Medicine Norway, University of Oslo, Blindern, P.O. Box 1137, 0318 Oslo, Norway.
  • Vågbø CB; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Lyle R; Department of Medical Genetics, University of Oslo, Oslo University Hospital, Oslo, Norway.
  • Kringen MK; Department of Pharmacology, Oslo University Hospital, Ullevål, Oslo, Norway.
  • Staff AC; Department of Obstetrics and Gynecology, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Dybedal I; Department of Haematology, Oslo University Hospital, Oslo, Norway.
  • Mills IG; Nordic European Molecular Laboratory (EMBL) Partnership, Centre for Molecular Medicine Norway, University of Oslo, Blindern, P.O. Box 1137, 0318 Oslo, Norway ; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway ; PCUK Movember Centre of Excellence
  • Klungland A; Clinic for Diagnostics and Intervention, Institute of Medical Microbiology, Oslo University Hospital, University of Oslo, Oslo, Norway ; Norwegian Center for Stem Cell Research, University of Oslo, Oslo, Norway.
  • Staerk J; Nordic European Molecular Laboratory (EMBL) Partnership, Centre for Molecular Medicine Norway, University of Oslo, Blindern, P.O. Box 1137, 0318 Oslo, Norway ; Department of Haematology, Oslo University Hospital, Oslo, Norway ; Norwegian Center for Stem Cell Research, University of Oslo, Oslo, Norwa
Article en En | MEDLINE | ID: mdl-27252783